The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Drug effects on the thyroid.
Abstract
The list of medications, many commonly used, that adversely affect thyroid function or the interpretation of standard thyroid tests is growing. This review addresses drug-induced thyroid dysfunction, emphasizing clinically relevant interactions and laboratory assay artifacts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Drug-induced hypothyroidism is caused by medications such as amiodarone, lithium, and immune checkpoint inhibitors ( Figure 1 ). 28,29”
From Hypothyroidism: A Review (2025) · cites this paper as [28]
In the citing paper
“while biotin may interfere with some T4 assay systems (79, 80).”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [79]
In the citing paper
“A number of drugs, such as phenytoin, carbamazepine, salsalate, salicylate, furosemide, diclofenac, ethacrynic acid, and heparin, have been observed in vitro to displace T4 from the distribution proteins, changing the amount of thyroxine bound to plasma protein”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [79]
In the citing paper
“Some of these drugs may also directly interfere with components and principles used for the hormone assays.136”
In the citing paper
“A number of medications can affect the thyroid function tests not only by interfering with the synthesis, transport, and metabolism of TSH and thyroid hormones but also by interfering with thyroid function immunoassays (30, 37–40) ( Table 1 ).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [37]
In the citing paper
“On the other hand, retinoids, mitotane and several drugs modulating the immune system and used for antineoplastic purpose may result in hypophysitis and cause clinically significant central hypothyroidism (Burch, 2019;Feldt-Rasmussen and Klose 2020;Feldt-Rasmussen and Rasmussen, 2018), as may head trauma including those related to sport and blast injuries (Benvenga et al., 2018).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Burch, 2019
In the citing paper
“Fortunately, most of these medications do not cause clinically evident central hypothyroidism.”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Burch, 2019
In the citing paper
“A number of other medications and drugs of abuse reportedly increase TBG levels: selective oestrogen receptor modulators, tamoxifen, heroin, methadone, 5-fluorouracil, and mitotane [ 88 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
In the citing paper
“Firstly, therapeutic levels of phenytoin, carbamazepine, salsalate, salicylate, furosemide, fenclofenac, ethacrynic acid, and heparin induce the displacement of T4 from the binding proteins in vitro [ 87 , 88 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
In the citing paper
“Conversely, exposure to glucocorticoids, niacin, and androgens leads to a fall in TBG levels and thus a decrease in the LT4 requirement [ 88 , 92 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
Citations
Cites
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S. M., Négrier, S., Szczylik, C. A., Пили, Р., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,182
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Cella, D. F., Reeves, J. A., Hawkins, R. E., Guo, J., Nathan, P., Staehler, M. D., SOUZA, P. D., Merchan, J. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303989 · Cited by 1,928
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
Barroso-Sousa, R., Barry, W. T., Garrido-Castro, A. C., Hodi, F. S., Min, L., Krop, I. E., & Tolaney, S. M. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3064 · Cited by 1,115
Lithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 881
Bertrand, A., Kostine, M., Barnetche, T., Truchetet, M.-E., & Schaeverbeke, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0455-8 · Cited by 704
Research works printed but not linked: 4
- Kopp P, 2013, In: Braverman LE, Cooper DS, eds. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 10th ed, 48
- Duvic M, 2001, Arch Dermatol, 137, 581
- Martino E, 2001, Endocr Rev, 22, 240
- 10.1001/jama.1996.03530430039036 · DOI · Paper page
Cited by
Sorted by citations
Items 101–164 of 164
Management of thyroid disorders in older people
Godbole, G., Joshi, T., & Majumder, M. (2023) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1883 · Cited by 1
Wu, S., Yang, Y., Chen, Y., Xie, W., Huang, J., Liu, M., Liu, Y., Xu, D., Lyu, X., Wu, H., et al. (2024) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2024.114338 · Cited by 1
Thyrotoxic crisis induced by amiodarone
Bystrianska, M., Bystriansky, A., Wildová, I., & Opravilová, L. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.052 · Cited by 1
Gender-Specific DNA Methylation Profiles Associated with Adult Weight in Hezuo Pigs
Jia, R., Huang, X., Yang, J., Wang, L., Li, J., Li, Y., Gun, S., Yan, Z., Wang, P., & Yang, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111488 · Cited by 1
Alshammari, F. D. (2019) · Bioinformation · doi:10.6026/97320630015633 · Cited by 1
Severe Thyrotoxicosis and Thyroid Storm
Lechner, M. G., & Angell, T. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-38976-5_4 · Cited by 1
Schilddrüsenfunktionsstörungen im Alter
Iwen, A. (2022) · Geriatrie up2date · doi:10.1055/a-1561-9335 · Cited by 1
Myxedema coma following rifampicin – A clinical case and literature review
Saraiva, M., Maia, A., de Assunção, G. V., Freitas, C., & Carvalho, A. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.09.019 · Cited by 1
Thyroid disease: monitoring and management guidelines
Matthews, J. J., Matheny, L. N., & Jagasia, S. (2021) · doi:10.1002/9781119612780.ch19 · Cited by 1
Serum thyroid hormone-binding proteins
Bartalena, L., Gallo, D., & Piantanida, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00005-4 · Cited by 1
Launch Price and Advertising as Strategic Substitutes: Evidence from Pharmaceutical MarketsPreprint
Nagpal, G. K., Grewal, R., Jena, D., & Nerkar, A. A. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.3024095
Yodo tópico y glándula tiroidea. ¿Se debe tomar alguna precaución?
Guerra, L. C., Pérez, A. M. C., & Olmo-Montes, F. J. (2020) · Atención Primaria · doi:10.1016/j.aprim.2019.12.005
Wirkung von Medikamenten auf die Schilddrüse
WEISSEL, M. (2020) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-020-00099-5
C’è un problema con la tiroide? Attenzione ai farmaci!
Trimarchi, F., & Ruggeri, R. M. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00719-x
Alemtuzumab-Induced Autoimmune Thyroid Disease Improves Clinical Response in Multiple Sclerosis
Mammen, J. S., & Cooper, D. S. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.205-208
Schilddrüsenfunktionsstörungen im Alter
Iwen, A. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1239-3066
Drug-Induced Central Hypothyroidism
Gigliotti, B. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_12
(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23841-3.00041-2
Newman, S. K., & Davies, T. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00120-1
Dominguez, L. J., & Barbagallo, M. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch83
Anvari, E., Fateh, A., & Zadeh, A. N. (2021) · journal of ilam university of medical sciences · doi:10.52547/sjimu.29.6.59
Maladies générales, médicaments et fonction thyroïdienne
Balavoine, A.-S. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77583-3.00022-8
General Preoperative Considerations and Preparation of the Patient for Surgery
Bojar, R. M. (2020) · Wiley eBooks · doi:10.1002/9781119582540.ch3
(2022) · Wiley eBooks · doi:10.1002/9783527838561.ch18
(2022) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477251-3
Deligiorgi, M. V., & Trafalis, D. T. (2022) · Personalized Medicine · doi:10.2217/pme-2022-0052
Part II : Interactive case: Drug‐induced endocrine disorders
Donihi, A. C. (2023) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1813
Hypothyroidism with Nephrotic Syndrome Misdiagnosed as Cardiac Failure
Malik, B. H., & Hameed, M. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-28296-6_22
Zhan, L., Gao, Y., Zeng, K., Li, Y., & Ma, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3174170/v1
Ford, S. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-14372-4_1
Schilddrüsenfunktionsstörungen im Alter
Iwen, A. (2023) · Angewandte Nuklearmedizin · doi:10.1055/a-2030-6758
Mikulevič, J., Tumelienė, K., Kemežys, R., & Jankauskienė, A. (2023) · Acta medica Lituanica · doi:10.15388/amed.2023.30.2.4
LEVEL OF SERUM PROLACTIN IN THYROID ASSOCIATED CANCER PATIENTS IN THE SUMMON AREA OF SINDH PAKISTAN
Seelro, M. Y., Kandhro, A. A., Laghari, A. Q., Gishkori, K. A., Talpur, M. Y., Inayatullah, I., Memon, A. A., Memon, S. M., & memon, M. A. (2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555/jptcp.v30i19.3748
Efectos endocrinos y metabólicos iatrogénicos de los fármacos
Olabe, J., & Tauveron, I. (2023) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(23)48732-6
Stijgend gebruik van levothyroxine in België
Boets, L., den Bruel, A. V., haecht, C. V., Cornelis, K., Debbaut, B., Ntahonganyira, R.-M., Flamaing, J., Stokx, J., & Decallonne, B. (2024) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.79.23.122
(2024) · Journal of Oral and Dental Research · doi:10.58827/863068dzeain
Current Assays in Endocrine Safety Pharmacology
Sandow, J., Pirchio, R., Scairati, R., & Colao, A. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_76-1
Ko, M. Y., Barai, R., & Brent, G. A. (2024) · Cureus · doi:10.7759/cureus.71551
Current Assays in Endocrine Safety Pharmacology
Sandow, J., Pirchio, R., Scairati, R., & Colao, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_76
Guglielmi, R., Mian, C., Andreoli, C., Bagnasco, M., Boniardi, M., Menis, E. D., Rimini, M. L. D., Tina, D., Fiorentini, G., Locantore, P., et al. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01601-4
Hypothyroidism: from diagnosis to therapy success. A review
Biryukova, E. V., & Abramova, A. D. (2025) · Consilium Medicum · doi:10.26442/20751753.2025.4.203294
Klingaman, C. E., Callahan, C., Deveau-Rosen, S. H., Gibson, C., Lazareva, O., Moyer, K., & Port, C. M. (2025) · Pediatric Quality and Safety · doi:10.1097/pq9.0000000000000841
Pharmacological Interactions of Levothyroxine in Multiple-Treated Patients
Marco, F. D., & Cusini, C. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_14
The problem of hypothyroidism today: Current challenges and solutions
Biryukova, E. V., Platonova, N. M., & Викторович, Ш. М. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-3-08
Case 33-2025: A 27-Year-Old Man with Abnormal Behaviors, Confusion, and Seizure
Quijije, N. V., Heidari, P., Rengarajan, M., & Adams, C. N. (2025) · New England Journal of Medicine · doi:10.1056/nejmcpc2412523
Aimaganova, A., Khovanova, N. A., Braybrook, E., Vryonis, E., Anderson, N. R., Young, L. S., & Grammatopoulos, D. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-25434-1
Drug effects and thyroid function
Klose, M., Feldt‐Rasmussen, U., & Rasmussen, Å. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00300-9
The Risk of Hypothyroidism With the Use of GLP ‐1 Receptor Agonists in Saudi Arabia
Alfakhri, A., Almadani, O. A., Alroba, R., Alrwisan, A. A., Alshaya, O. A., & Albogami, Y. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70315
Tater, A., Rudresh, B. B., & Gaonkar, S. L. (2026) · Drug and Chemical Toxicology · doi:10.1080/01480545.2025.2606102
Growth hormone: Synthesis and regulation
Iglesias, P., & Guerrero‐Pérez, F. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2025.10.001
Zhong, W., Ruan, L., Tan, C., Marimuthu, K., De, P. P., Ng, O. T., Zhu, Y., Hammond, P. T., Chan‐Park, M. B. E., & Zhang, K. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c22543
Gao, X., Chang, W., Sun, K., Liu, B., Ruan, Q., Han, X., & Wang, R. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02833-3
Thyroid Function Testing in Hospitalized Patients: A Practical Framework for Clinicians
Shapoo, N., & Boma, N. (2026) · Cureus · doi:10.7759/cureus.106544
Heldal, A. T., Vold, J. H., Viste, K., Chalabianloo, F., Mellgren, G., Johansson, K. A., & Fadnes, L. T. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag079
Risk of post-contrast thyroid dysfunction in non-toxic goiter: a matched cohort study
Lee, W., Kor, C., & Liu, Y. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag069
The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice
Shapoo, N., Boma, N., Gotlieb, V., Mattana, J., Belokovskaya, R., & Franco, A. (2026) · Medical Sciences · doi:10.3390/medsci14030347
Limitaciones en la interpretación de los análisis de función tiroidea
Galofré, J. C. (2026) · Medicina Clínica · doi:10.1016/j.medcli.2026.107492
Gonzalez, A., Chalif, J., O'Connor, R. M., McLaughlin, E., Morton, M. A., Fulton, J., Velasquez, J., Cohn, D. E., Cosgrove, C. M., Copeland, L. J., et al. (2026) · Gynecologic Oncology · doi:10.1016/j.ygyno.2026.09.006
Miller, G., & Carleton, L. (2026) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2026.09.035
Batrash, F., Jamal, F., Jasti, S., Belanger, J. A., Reiad, T. A., Mahmoud, T., Iqbal, A., Allahverdian, A., Diebo, B. G., Basques, B. A., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197714
Hashimoto's thyroiditis: two decades on
Duntas, L. H., & Effraimidis, G. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00189-0
Ebanoidze, L., Koval, A. A., Pigarova, E. A., Dzeranova, L. K., Starostina, E. A., Орлова, К. В., Nikankina, L. V., Kolesnikova, G. S., & Platonova, N. M. (2026) · Clinical and experimental thyroidology · doi:10.14341/ket12852
Limitations in the interpretation of thyroid function tests
Galofré, J. C. (2026) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2026.107492
Metadata
- Authors
- Burch, H. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Burch, Henry B.
- ORCID
- Burch, Henry B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-08-22
- Volume
- 381
- Issue
- 8
- Pages
- 749-761
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2969848078
- Cited by
- 164
- References
- 78
- Citations by year
- 2026: 22 · 2025: 20 · 2024: 20 · 2023: 23 · 2022: 25 · 2021: 23 · 2020: 26 · 2019: 3
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- drug-induced thyroid dysfunction, thyroid function tests, drug interactions, adverse drug reactions, thyroid hormones
- MeSH terms
- Pharmaceutical Preparations, Humans, Thyroid Gland, Thyroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
